Ripon College working with Eli Lilly to screen molecules for potential pharmaceutical use
Ripon College now is affiliated with the Open Innovation Drug Discovery Program at Eli Lilly. Through this program, students and faculty will use the technology at Eli Lilly to virtually screen molecules for their potential to be pharmaceuticals. After virtual screening, students and faculty will send molecules prepared at Ripon College to Eli Lilly for actual biological testing.
This program allows students and faculty to use their research to directly participate in the discovery of new pharmaceuticals. For example, several students in Assistant Professor of Chemistry Patrick Willoughby’s research lab have synthesized many completely new molecules. These molecules now can be assessed for their viability to treat disease and other ailments.
“I am excited to see student research at Ripon College directly contribute to the discovery of new drugs,” Willoughby says. “This undoubtedly will enhance their understanding of modern medicine and positively affect the prospect of them pursuing a career in health sciences.”
Jacqueline Clark, professor of sociology and the Helen Swift Neilson Professor of Cultural Studies; Kaeley Miller ’24 of Norway, Michigan; and Alison DeNamur ’25 of […]
A National Science Foundation grant worth more than $259,000 over four years has been awarded for an interdisciplinary research study led by Associate Professor of […]
Assistant Professor of Theatre Lillian Brown will appear in a professional production of “The Mousetrap” Nov. 25-Dec. 17 at Next Act Theatre in Milwaukee. Agatha […]
A variety of musical solo and chamber works will be presented in a concert Thursday, Dec. 7, at Ripon College. The recital will begin at […]